e-learning
resources
European Respiratory Review
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung involvement in monogenic interferonopathies
Salvatore Cazzato, Alessia Omenetti, Claudia Ravaglia, Venerino Poletti
Source:
Eur Respir Rev, 29 (158) 200001; 10.1183/16000617.0001-2020
Journal Issue:
December
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Salvatore Cazzato, Alessia Omenetti, Claudia Ravaglia, Venerino Poletti. Lung involvement in monogenic interferonopathies. Eur Respir Rev, 29 (158) 200001; 10.1183/16000617.0001-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Definition and history of sarcoidosis
Evidence of early abnormal airways’ inflammation in children with type 1 diabetes
Consistent effect of nintedanib on reducing FVC decline across interstitial lung diseases (ILDs)
Related content which might interest you:
Lung involvement in autoimmune liver diseases
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019
Lung function in Birt-Hogg-Dubé syndrome
Source: International Congress 2017 – From idiopathic pulmonary fibrosis (IPF) to rare diseases
Year: 2017
Comparative phenotype and BTNL2 polymorphism in familial and sporadic sarcoidosis in the French SARCFAM cohort
Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis
Year: 2014
Lung pathology in COVID-19
Source: Eur Respir Monogr 2021; 94: 86-100
Year: 2021
Phenotype heterogeneity in a familial "brain lung thyroid syndrome" related to a novel NKX-2.1 mutation
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer
Source: International Congress 2016 – IPF pathogenesis
Year: 2016
Lung abnormalities in marfan syndrome: a pathogenetic model of early-onset emphysema?
Source: Annual Congress 2009 - Respiratory physiology
Year: 2009
Management of suspected monogenic lung fibrosis in a specialised centre
Source: Eur Respir Rev, 26 (144) 160122; 10.1183/16000617.0122-2016
Year: 2017
Lung cancer and paraneoplastic syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 93s
Year: 2006
Lung Embryology, congenital abnormalities
Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
Year: 2009
Pregnancy course in patients with interstitial lung diseases
Source: International Congress 2014 – ILDs 5
Year: 2014
Verification of genetic associations with Scleroderma associated Interstitial Lung Disease
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Year: 2019
Does the
BTNL2
genotype influence the course of disease in Danish sarcoidosis patients?
Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations
Year: 2014
Aetiological panorama in the diagnosis of interstitial lung diseases
Source: International Congress 2014 – ILDs 5
Year: 2014
HCMV infection triggers the development of interstitial lung diseases in autoimmune disorders
Source: International Congress 2014 – IPF and surroundings
Year: 2014
Lung cancer and associated diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 66s
Year: 2001
Lung function decline in patients with severe alpha
1
-antitrypsin deficiency
Source: International Congress 2014 – Respiratory function: quality and new technologies
Year: 2014
European pulmonary alveolar proteinosis network (EuPAPNet): Results from biomarkers´ investigation
Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis
Year: 2014
Neuroendocrine cell hyperplasia (NEHI) and NEHI Syndrome: Lung biopsy necessary?
Source: International Congress 2014 – ILDs 4
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept